IDEXX LABORATORIES, INC. (NASDAQ:IDXX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 of the Original Report in its entirety solely to add a
new second paragraph that clarifies that there are no related
person transactions reportable under Item 5.02(d) of Form 8-K and
Item 404(a) of Regulation S-K. No other changes were made to the
Original Report. References to the exhibit in this Amendment are
references to the exhibit filed with the Original Report.
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;Compensatory Arrangements of Certain Officers. |
Election of New Director. On October
19, 2016, the board of directors (the Board) of IDEXX
Laboratories, Inc. (the Company) elected Lawrence D. Kingsley as
an independent Class II Director and a member of its Compensation
and Finance Committees effective that date. To accommodate Mr.
Kingsleys election as a Class II Director, the Board increased
the number of Directors constituting the Board from nine to ten
and the number of Class II Directors from three to four. It is
expected that Mr. Kingsley will stand for election by
stockholders as a Class II Director at the 2017 annual meeting of
stockholders, with a three-year term expiring in 2020.
There are no related person transactions (or proposed related
person transactions) with respect to Mr. Kingsley reportable
under Item 5.02(d) of Form 8-K and Item 404(a) of Regulation S-K
since the beginning of the Companys last fiscal year.
Mr. Kingsley will receive the same compensation as is paid to the
Companys other nonemployee Directors as described in the section
entitled Corporate Governance Director Compensation in the
Companys Proxy Statement filed with the Securities and Exchange
Commission on March 24, 2016, which description is incorporated
herein by reference. The cash fee to be paid to Mr. Kingsley in
the fourth quarter of 2016 will be prorated to reflect the
effective date of his election to the Board on October19, 2016.
Annual deferred stock unit and stock option grants were made to
Directors on May 4, 2016, the date of the 2016 Annual Meeting.
Since Mr.Kingsley was not serving as a Director at that time,
such grants will be made to him on December 1, 2016, and the
award values will be prorated to reflect the portion of the year
during which he will serve on the Board, specifically from the
effective date of his election on October 19, 2016 until the
Companys 2017 annual meeting of stockholders.
.
On October 19, 2016, the Company issued a press release regarding
Mr. Kingsleys election to the Board. A copy of the press release
is furnished as Exhibit 99.1 to this Form 8-K.
About IDEXX LABORATORIES, INC. (NASDAQ:IDXX)
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company’s segments include Companion Animal Group (CAG), which develops, designs, manufactures and distributes products and performs services for veterinarians and the bioresearch market; Water, which develops, designs, manufactures and distributes a range of products used in the detection of various microbiological parameters in water; Livestock, Poultry and Dairy (LPD), which develops, designs, manufactures and distributes diagnostic tests and related instrumentation, and performs services that are used to manage the health status of livestock and poultry and to expand bovine reproductive productivity, and Other, which develops, designs, manufactures and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market. IDEXX LABORATORIES, INC. (NASDAQ:IDXX) Recent Trading Information
IDEXX LABORATORIES, INC. (NASDAQ:IDXX) closed its last trading session up +0.21 at 141.95 with 407,324 shares trading hands.